Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MBII

Marrone Bio Innovations (MBII) Stock Price, News & Analysis

Marrone Bio Innovations logo

About Marrone Bio Innovations Stock (NASDAQ:MBII)

Advanced Chart

Key Stats

Today's Range
$0.80
$0.80
50-Day Range
$0.80
$0.80
52-Week Range
$0.55
$1.55
Volume
38 shs
Average Volume
919,497 shs
Market Capitalization
$145.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MBII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marrone Bio Innovations and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MBII Stock News Headlines

Upstream Bio Inc
Upstream Bio Inc (UPB)
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
Man shot, killed by Olive Branch SWAT team
See More Headlines

MBII Stock Analysis - Frequently Asked Questions

Marrone Bio Innovations, Inc. (NASDAQ:MBII) released its earnings results on Wednesday, November, 10th. The basic materials company reported ($0.03) EPS for the quarter, meeting the consensus estimate of ($0.03). The basic materials company had revenue of $9.86 million for the quarter, compared to analysts' expectations of $10.79 million. Marrone Bio Innovations had a negative net margin of 47.07% and a negative trailing twelve-month return on equity of 70.87%.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Marrone Bio Innovations investors own include ObsEva (OBSV), Amyris (AMRS), Avino Silver & Gold Mines (ASM), Rexahn Pharmaceuticals (REXN), Plug Power (PLUG), Denali Therapeutics (DNLI) and

Company Calendar

Last Earnings
11/10/2021
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Agricultural Chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:MBII
CIK
1441693
Fax
N/A
Employees
153
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.12)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.55 million
Net Margins
-47.07%
Pretax Margin
-47.12%
Return on Equity
-70.87%
Return on Assets
-25.23%

Debt

Debt-to-Equity Ratio
0.33
Current Ratio
0.79
Quick Ratio
0.55

Sales & Book Value

Annual Sales
$44.31 million
Price / Sales
3.28
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.17 per share
Price / Book
4.69

Miscellaneous

Outstanding Shares
182,378,000
Free Float
173,259,000
Market Cap
$145.56 million
Optionable
Not Optionable
Beta
0.36

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:MBII) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners